Search Count: 23
![]() |
Crystal Structure Of The Sars-Cov-2 Main Protease Inhibited By (2-Methylsulfanyl-6,7-Dihydro-[1,4]Dioxino[2,3-F]Benzimidazol-3-Yl)-(P-Tolyl)Methanone
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2025-01-01 Classification: VIRAL PROTEIN Ligands: 4MA, DMS, GOL, FMT, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: 4MA, DMS, GOL, FMT, NA
![]() |
Sars-Cov-2 Main Protease Complexed With (1R)-N-(3-Chlorophenyl)-3-Oxo-Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: DMS, A1ITO, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: DMS, A1ITO, GOL
![]() |
Sars-Cov-2 Main Protease Complexed With (1R)-N-(3-Chlorophenyl)-3-Oxo-N-[4-(2-Oxopyrrolidin-1-Yl)Phenyl]Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1ITP, DMS, GOL, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1ITP, DMS, GOL, NA
![]() |
Sars-Cov-2 Main Protease In Complex With With (1R)-N-(3-Chlorophenyl)-N-[4-(2,4-Dioxo-1H-Pyrimidin-5-Yl)Phenyl]-3-Oxo-Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1ITV, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1ITV, NA
![]() |
Sars-Cov-2 Main Protease In Complex With (3S)-3-[(3R)-3-Phenylpiperidine-1-Carbonyl]Indan-1-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: DMS, A1ITW, FMT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: DMS, A1ITW, FMT
![]() |
Sars-Cov-2 Main Protease In Complex With (3R)-3-[(3R)-4-Benzyl-3-Phenyl-Piperidine-1-Carbonyl]Indan-1-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1IT1, FMT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1IT1, FMT
![]() |
Sars-Cov-2 Main Protease In Complex With (1R)-3-Oxo-N-[2-Oxo-2-(N-Phenylanilino)Ethyl]Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1IT2 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1IT2
![]() |
Vhh H3-2 In Complex With Tau C-Terminal Peptide
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-07-31 Classification: IMMUNE SYSTEM |
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-07-31
![]() |
Vhh Z70 Mutant 3 In Interaction With Phf6 Tau Peptide
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2023-07-05 Classification: IMMUNE SYSTEM |
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-07-05
![]() |
Vhh Z70 Mutant 20 In Interaction With Phf6 Tau Peptide
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2023-05-31 Classification: IMMUNE SYSTEM |
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-05-31
![]() |
Vhh Z70 Mutant 1 In Interaction With Phf6 Tau Peptide
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2023-05-31 Classification: IMMUNE SYSTEM |
Organism: Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-05-31
![]() |
Sars-Cov-2 Main Protease Complexed With N-(Pyridin-3-Ylmethyl)Thioformamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2023-03-15 Classification: VIRAL PROTEIN Ligands: DMS, 35J, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-03-15
Ligands: DMS, 35J, NA
![]() |
Crystallographic Structure Of Human Tsg101 Uev Domain In Complex With A Hev Orf3 Peptide
Organism: Homo sapiens, Hepatitis e virus
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2022-03-02 Classification: PROTEIN TRANSPORT Ligands: CL, SO4, NH4 |
Organism: Homo sapiens, Hepatitis e virus
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
Ligands: CL, SO4, NH4
![]() |
Crystal Structure Of The Sars-Cov-2 Main Protease Complexed With N-(Pyridin-3-Ylmethyl)Thioformamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN Ligands: 35J, NA, FMT, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
Ligands: 35J, NA, FMT, DMS
![]() |
Crystal Structure Of The Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
![]() |
Crystal Structure Of The Sars-Cov-2 Main Protease With A Zinc Ion Coordinated In The Active Site
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
![]() |
Vhh Z70 In Interaction With Phf6 Tau Peptide
Organism: Lama glama
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-12-08 Classification: IMMUNE SYSTEM Ligands: GOL |
Organism: Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2021-12-08
Ligands: GOL
![]() |
Crystal Structure Of The Sars-Cov-2 Main Protease With Oxidized C145
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2021-10-06 Classification: VIRAL PROTEIN Ligands: DMS, GOL, FMT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: DMS, GOL, FMT
![]() |
Crystal Structure Of The Sars-Cov-2 Main Protease Complexed With Fragment F01
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2021-10-06 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
![]() |
Nmr Structure Of Ns5A-D2 (Jfh1) Peptide (304-323)
Organism: Hepacivirus c
Method: SOLUTION NMR Release Date: 2019-07-24 Classification: UNKNOWN FUNCTION |
Organism: Hepacivirus c
Method: SOLUTION NMR
Release Date: 2019-07-24
